Sugi Predict

Sugi Predict / Compounds / SCHEMBL4926043

SCHEMBL4926043

SCHEMBL4926043

FC(F)(F)c1ccnnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.43
▸ NOS3 P29474 1/20 0.41
▸ NOS2 P35228 1/20 0.41
▸ KIF11 P52732 5/20 0.41
▸ VNN1 O95497 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ KMT2A Q03164 1/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.36
▸ HCAR2 Q8TDS4 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NOTUM Q6P988 1/20 0.32
▸ METAP2 P50579 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29770233 1.00 S1PR1 (0.43) S1PR1NOS3NOS2KIF11VNN1
Chlorobenzene SCHEMBL28481736 0.84 ALDH1A1 (0.41) S1PR1KIF11VNN1ALDH1A1TSHR
SCHEMBL26982566 0.80 VNN1 (0.37) S1PR1NOS3NOS2VNN1LOXL2
SCHEMBL25616488 0.80 VNN1 (0.37) S1PR1NOS3NOS2VNN1LOXL2
SCHEMBL5720526 0.76 HCAR2 (0.41) S1PR1LOXL2HCAR2
SCHEMBL28133515 0.75 KIF11 (0.65) S1PR1KIF11ALDH1A1NPC1KDM4E
SCHEMBL31750233 0.74 VNN1 (0.38) S1PR1NOS3NOS2VNN1GRIN1
SCHEMBL179254 0.74 KIF11 (0.39) KIF11VNN1ALDH1A1TSHRLOXL2
SCHEMBL173641 0.71 KIF11 (0.70) S1PR1NOS3NOS2KIF11ALDH1A1
SCHEMBL85670 0.70 LOXL2 (0.33) VNN1LOXL2HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240336629-A1 Tricyclic Derivatives Useful As PARP7 Inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-10-10 — — US claimed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 — — US claimed
US-20170012208-A1 ORGANIC SEMICONDUCTOR FORMULATIONS USINVEST LLC 2017-01-12 — — US claimed
CN-101648914-A Method for preparing 6-methyl-3-(3,4-dichloroanilino)-4-(3-trifluoromethylphenyl)pyridazine and phytocidal activity thereof UNIV NANKAI 2010-02-17 — — CN claimed
US-20250074897-A1 PYRIDAZINONES AS PARP7 INHIBITORS RIBON THERAPEUTICS INC (US) 2025-03-06 — — US disclosed
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS RIBON THERAPEUTICS, INC. 2025-01-30 — — US disclosed
CN-119330972-A PARP7 inhibitor and application thereof 重庆华森英诺生物科技有限公司 2025-01-21 — — CN disclosed
US-20240424614-A1 METAL PASTE FOR BONDING, AND BONDED BODY AND METHOD FOR PRODUCING SAME RESONAC CORPORATION (JP) 2024-12-26 — — US disclosed
US-20240336629-A1 Tricyclic Derivatives Useful As PARP7 Inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-10-10 — — US disclosed
CN-115745971-B PARP7 inhibitor and application thereof 北京华森英诺生物科技有限公司 2024-07-30 — — CN disclosed
US-20240190844-A1 PYRIDAZINONES AS PARP7 INHIBITORS RIBON THERAPEUTICS, INC. 2024-06-13 — — US disclosed
EP-4368316-A1 METAL PASTE FOR BONDING, AND BONDED BODY AND METHOD FOR PRODUCING SAME Resonac Corporation (JP) 2024-05-15 — — EP disclosed
WO-2015003951-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2015-01-15 — — WO disclosed
US-20140042369-A1 Organic Semiconductor Formulations USINVEST LLC 2014-02-13 — — US disclosed
CN-101648914-A Method for preparing 6-methyl-3-(3,4-dichloroanilino)-4-(3-trifluoromethylphenyl)pyridazine and phytocidal activity thereof UNIV NANKAI 2010-02-17 — — CN disclosed
US-20080214552-A1 Substituted Pyridazinecarboxamides and Derivatives Thereof BAYER CROPSCIENCE AG (DE) 2008-09-04 — — US disclosed
CN-1976585-A Substituted pyridazine carboxamides and derivatives thereof BAYER CROPSCIENCE AG (DE) 2007-06-06 — — CN disclosed
CN-1962642-A Trifluoromethylphenylpyridazine derivative and its preparation method UNIV NANKAI (CN) 2007-05-16 — — CN disclosed
EP-1763303-A1 SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF Bayer CropScience Aktiengesellschaft (DE) 2007-03-21 — — EP disclosed
WO-2006000333-A1 SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-01-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214552-A1 Substituted Pyridazinecarboxamides and Derivatives Thereof PFAS, CYP4Z1, CYP4F12 S1PR1 1031/4885NOS3 3146/4885NOS2 2831/4885
US-20240190844-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 S1PR1 1531/4885NOS3 3978/4885NOS2 4498/4885
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 S1PR1 1531/4885NOS3 3978/4885NOS2 4498/4885
US-20250074897-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 S1PR1 1531/4885NOS3 3978/4885NOS2 4498/4885
US-10224485-B2 Process for preparing a crystalline organic semiconductor material STOM, SPOP, TTR S1PR1 2243/4885NOS3 1998/4885NOS2 1540/4885
US-20240336629-A1 Tricyclic Derivatives Useful As PARP7 Inhibitors PARP1, PARP2, PARP11 S1PR1 3073/4885NOS3 4444/4885NOS2 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.